Deep TMS News - Get The Latest News On BrainsWay's Deep TMS

News & Events

March 4, 2019

BrainsWay Expands Intellectual Property Position by Obtaining Rights to Multi-Channel Transcranial Magnetic Stimulation Patent Portfolio

Acquires Multi-Channel TMS Patent Portfolio from TMS Innovations. Enters into an Exclusive Option Agreement...

February 20, 2019

BrainsWay Expands its Deep TMS Commercial Footprint into Asia Pacific

Enters into an Agreement to Distribute its Deep Transcranial Magnetic Stimulation System in South Korea.

January 29, 2019

BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder

Approval allows BrainsWay’s Deep TMS System to be marketed throughout Japan.

October 17, 2018

BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 Annual Psych Congress

Showcase represents the public debut of BrainsWay’s Deep TMS system for OCD Healthcare providers will...

June 7, 2018

BrainsWay and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder

Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress...

April 17, 2019

BrainsWay Ltd. Announces Pricing of Initial Public Offering of 2.5 Million American Depositary Shares

JERUSALEM, Israel, April 16, 2019 – BrainsWay Ltd. (NASDAQ: BWAY and TASE:BRIN) (“BrainsWay”)...

March 26, 2019

BrainsWay Reports Financial Results for Fourth Quarter and Full-Year 2018

Full-Year 2018 revenues of $16.4 million increased 47% over full-year 2017 Fourth quarter revenues of...

February 19, 2019

BrainsWay Receives FDA 510(k) Clearance for Use of its Next-Generation Stimulator for the Treatment of Obsessive Compulsive Disorder

Advances BrainsWay’s Leadership in Deep Transcranial Magnetic Stimulation (Deep TMS)

November 13, 2018

BrainsWay to Showcase FDA-Cleared Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at DGPPN 2018

Jerusalem, DATE: BrainsWay Ltd. (TASE: BRIN), a global leader in the advanced non-invasive treatment...

October 10, 2018

BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder

Twenty sites across the U.S. are the first to receive the BrainsWay Deep transcranial magnetic stimulation...

August 27, 2018

BrainsWay Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update

Second quarter revenues of $3.7 million represent a quarterly record and a 57% increase over second quarter...

August 19, 2018

BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Compulsive Disorder

BrainsWay’s deep transcranial magnetic stimulation (Deep TMS) system is a best-in-class device designed...

May 30, 2018

BrainsWay Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update

First quarter revenues of $3.6 million represent a quarterly record and a  68% increase over first quarter...

May 23, 2018

Achieve TMS Announces Grand Opening of New Location in Newton, Massachusetts

NEWTON, Mass., May 23, 2018 (GLOBE NEWSWIRE) — Achieve TMS, the largest U.S. provider of BrainsWay’s...

May 6, 2018

BrainsWay Receives FDA Clearance of Next Generation Stimulator

The company will now have the most advanced stimulator on the market, with enhanced features that increase...

January 10, 2013

BrainsWay Receives FDA Clearance

JERUSALEM, Thursday 10, 2013 BrainsWay® Ltd. (TASE: BRIN)  is proud to announce that the U.S. Food...